Predicting efficacies of anticancer drugs using single cell HaloChip assay

Area of Science:

• Biotechnology
• Molecular Biology
• Cancer Research

Background:

• DNA repair mechanisms are crucial for cellular integrity and response to chemotherapy.
• Predicting anticancer drug efficacy requires accurate assessment of cellular DNA repair capacity.
• Existing methods for DNA repair quantification can be complex or lack single-cell resolution.

Purpose of the Study:

• To introduce and validate the Single Cell Halo Assay (HaloChip) for quantifying DNA repair ability.
• To demonstrate the utility of HaloChip in predicting anticancer drug efficacy.
• To explore the application of HaloChip in evaluating drug-inhibitor combinations for enhanced chemotherapy.

Main Methods:

• Cells are exposed to drugs and patterned into single-cell arrays on a substrate.
• Cells are embedded in agarose gel and fluorescently stained to form halos.
• DNA repair is quantified using a relative nuclear diffusion factor (rNDF) based on nuclear and halo surface areas.

Main Results:

• HaloChip successfully quantified DNA repair ability across various repair-competent and deficient cell lines.
• The assay demonstrated diagnostic utility in predicting anticancer drug efficacy.
• Drug-inhibitor combinations were effectively tested, showing potentiation of DNA damaging agents.

Conclusions:

• HaloChip is a valuable tool for quantifying DNA repair at the single-cell level.
• This assay provides diagnostic utility for enhancing anticancer drug effectiveness.
• HaloChip facilitates the study of synthetic lethality and optimization of combination cancer therapies.